Cannabidiol for people with schizophrenia
Research output: Contribution to journal › Journal article › Research › peer-review
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.
| Original language | English |
|---|---|
| Article number | CD014602 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2022 |
| Issue number | 11 |
| ISSN | 1465-1858 |
| DOIs | |
| Publication status | Published - 2022 |
Bibliographical note
Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Links
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667351/pdf/CD014602.pdf
Final published version
ID: 340548900